cDNA sequencing improves the detection of <it>P53 </it>missense mutations in colorectal cancer

<p>Abstract</p> <p>Background</p> <p>Recently published data showed discrepancies beteween <it>P53 </it>cDNA and DNA sequencing in glioblastomas. We hypothesised that similar discrepancies may be observed in other human cancers.</p> <p>Methods<...

Full description

Bibliographic Details
Main Authors: Jesionek-Kupnicka Dorota, Stawski Robert, Zawlik Izabela, Kulczycka-Wojdala Dominika, Pasz-Walczak Grazyna, Rieske Piotr, Zakrzewska Magdalena, Szybka Malgorzata, Liberski Pawel P, Kordek Radzislaw
Format: Article
Language:English
Published: BMC 2009-08-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/278
_version_ 1818359998654185472
author Jesionek-Kupnicka Dorota
Stawski Robert
Zawlik Izabela
Kulczycka-Wojdala Dominika
Pasz-Walczak Grazyna
Rieske Piotr
Zakrzewska Magdalena
Szybka Malgorzata
Liberski Pawel P
Kordek Radzislaw
author_facet Jesionek-Kupnicka Dorota
Stawski Robert
Zawlik Izabela
Kulczycka-Wojdala Dominika
Pasz-Walczak Grazyna
Rieske Piotr
Zakrzewska Magdalena
Szybka Malgorzata
Liberski Pawel P
Kordek Radzislaw
author_sort Jesionek-Kupnicka Dorota
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Recently published data showed discrepancies beteween <it>P53 </it>cDNA and DNA sequencing in glioblastomas. We hypothesised that similar discrepancies may be observed in other human cancers.</p> <p>Methods</p> <p>To this end, we analyzed 23 colorectal cancers for <it>P53 </it>mutations and gene expression using both DNA and cDNA sequencing, real-time PCR and immunohistochemistry.</p> <p>Results</p> <p>We found <it>P53 </it>gene mutations in 16 cases (15 missense and 1 nonsense). Two of the 15 cases with missense mutations showed alterations based only on cDNA, and not DNA sequencing. Moreover, in 6 of the 15 cases with a cDNA mutation those mutations were difficult to detect in the DNA sequencing, so the results of DNA analysis alone could be misinterpreted if the cDNA sequencing results had not also been available. In all those 15 cases, we observed a higher ratio of the mutated to the wild type template by cDNA analysis, but not by the DNA analysis. Interestingly, a similar overexpression of <it>P53 </it>mRNA was present in samples with and without <it>P53 </it>mutations.</p> <p>Conclusion</p> <p>In terms of colorectal cancer, those discrepancies might be explained under three conditions: 1, overexpression of mutated <it>P53 </it>mRNA in cancer cells as compared with normal cells; 2, a higher content of cells without <it>P53 </it>mutation (normal cells and cells showing <it>K-RAS </it>and/or <it>APC </it>but not <it>P53 </it>mutation) in samples presenting <it>P53 </it>mutation; 3, heterozygous or hemizygous mutations of <it>P53 </it>gene. Additionally, for heterozygous mutations unknown mechanism(s) causing selective overproduction of mutated allele should also be considered. Our data offer new clues for studying discrepancy in <it>P53 </it>cDNA and DNA sequencing analysis.</p>
first_indexed 2024-12-13T20:53:48Z
format Article
id doaj.art-c6cca4ad51f7482a93a888bd4699842a
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-13T20:53:48Z
publishDate 2009-08-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-c6cca4ad51f7482a93a888bd4699842a2022-12-21T23:31:48ZengBMCBMC Cancer1471-24072009-08-019127810.1186/1471-2407-9-278cDNA sequencing improves the detection of <it>P53 </it>missense mutations in colorectal cancerJesionek-Kupnicka DorotaStawski RobertZawlik IzabelaKulczycka-Wojdala DominikaPasz-Walczak GrazynaRieske PiotrZakrzewska MagdalenaSzybka MalgorzataLiberski Pawel PKordek Radzislaw<p>Abstract</p> <p>Background</p> <p>Recently published data showed discrepancies beteween <it>P53 </it>cDNA and DNA sequencing in glioblastomas. We hypothesised that similar discrepancies may be observed in other human cancers.</p> <p>Methods</p> <p>To this end, we analyzed 23 colorectal cancers for <it>P53 </it>mutations and gene expression using both DNA and cDNA sequencing, real-time PCR and immunohistochemistry.</p> <p>Results</p> <p>We found <it>P53 </it>gene mutations in 16 cases (15 missense and 1 nonsense). Two of the 15 cases with missense mutations showed alterations based only on cDNA, and not DNA sequencing. Moreover, in 6 of the 15 cases with a cDNA mutation those mutations were difficult to detect in the DNA sequencing, so the results of DNA analysis alone could be misinterpreted if the cDNA sequencing results had not also been available. In all those 15 cases, we observed a higher ratio of the mutated to the wild type template by cDNA analysis, but not by the DNA analysis. Interestingly, a similar overexpression of <it>P53 </it>mRNA was present in samples with and without <it>P53 </it>mutations.</p> <p>Conclusion</p> <p>In terms of colorectal cancer, those discrepancies might be explained under three conditions: 1, overexpression of mutated <it>P53 </it>mRNA in cancer cells as compared with normal cells; 2, a higher content of cells without <it>P53 </it>mutation (normal cells and cells showing <it>K-RAS </it>and/or <it>APC </it>but not <it>P53 </it>mutation) in samples presenting <it>P53 </it>mutation; 3, heterozygous or hemizygous mutations of <it>P53 </it>gene. Additionally, for heterozygous mutations unknown mechanism(s) causing selective overproduction of mutated allele should also be considered. Our data offer new clues for studying discrepancy in <it>P53 </it>cDNA and DNA sequencing analysis.</p>http://www.biomedcentral.com/1471-2407/9/278
spellingShingle Jesionek-Kupnicka Dorota
Stawski Robert
Zawlik Izabela
Kulczycka-Wojdala Dominika
Pasz-Walczak Grazyna
Rieske Piotr
Zakrzewska Magdalena
Szybka Malgorzata
Liberski Pawel P
Kordek Radzislaw
cDNA sequencing improves the detection of <it>P53 </it>missense mutations in colorectal cancer
BMC Cancer
title cDNA sequencing improves the detection of <it>P53 </it>missense mutations in colorectal cancer
title_full cDNA sequencing improves the detection of <it>P53 </it>missense mutations in colorectal cancer
title_fullStr cDNA sequencing improves the detection of <it>P53 </it>missense mutations in colorectal cancer
title_full_unstemmed cDNA sequencing improves the detection of <it>P53 </it>missense mutations in colorectal cancer
title_short cDNA sequencing improves the detection of <it>P53 </it>missense mutations in colorectal cancer
title_sort cdna sequencing improves the detection of it p53 it missense mutations in colorectal cancer
url http://www.biomedcentral.com/1471-2407/9/278
work_keys_str_mv AT jesionekkupnickadorota cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT stawskirobert cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT zawlikizabela cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT kulczyckawojdaladominika cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT paszwalczakgrazyna cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT rieskepiotr cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT zakrzewskamagdalena cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT szybkamalgorzata cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT liberskipawelp cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer
AT kordekradzislaw cdnasequencingimprovesthedetectionofitp53itmissensemutationsincolorectalcancer